Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)
Julie Wang(Shanghai Jiao Tong University), Charlotte Cunningham‐Rundles(Icahn School of Medicine at Mount Sinai)
Cited by 200
Related Papers
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|676
X-Linked Agammaglobulinemia
|Medicine|2006|637
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|504